We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Notice for sirolimus, rapamycin (AFT Pharmaceuticals Limited)
Active ingredients
sirolimus, rapamycin
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
topical cream
Indication
Treatment of facial angiofibromas associated with Tuberous Sclerosis Complex (TSC)
Therapeutic area
Dermatology